Pamala Pawloski, PharmD

Clinical pharmacy researcher

Joined the Institute

2008

Education

Pharm.D. North Dakota State University; pharmacy practice residency and oncology pharmacy practice residency, University of Kentucky; clinical pharmacology fellowship, University of Texas M.D. Anderson Cancer Center.

Research highlights

Site primary investigator (PI) for the Cancer Research Network (CRN) within the HMO Research Network (HMORN) and the U.S. Food and Drug Administration-sponsored Mini-Sentinel Drug Surveillance Program.  

Research interests/expertise

Oncology clinical pharmacy, clinical pharmacology, improving patient care and outcomes by improving medication management through enhanced identification of adverse reactions and subsequent reporting, increased medical therapy-management programs, and application of pharmacogenomic testing methods to enhance treatment optimization.

Current projects

  • Neuropenia Risk Modeling among Patients with Cancer using Electronic Data Sources
  • Patient Outcomes Research to Advance Learning (PORTAL): Colorectal cancer substudy
  • Mini-Sentinel Initiative Surveillance Program
  • The Medication Exposure in Pregnancy Risk Evaluation Program
  • Building Capability to Conduct Population-based Research on Cancer During Pregnancy Pilot Project 

Publications

Contact information

Office: 952-967-5030
Email: Pamala.A.Pawloski@HealthPartners.com

pawloski-pam-image